SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Myogen (MYOG)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: kenhott3/9/2006 9:44:37 AM
  Read Replies (1) of 50
 
street.com beats MYOG with an ugly stick using 5 pages. Going with the you are ugly, your mom is ugly, your dog is ugly, and your cat is ugly approach.

thestreet.com

Too long to cut and paste. But here are the parts that I like.

...Robert Lawton, a vice president at Westport, Conn.-based Source Capital who is short the stock.

...Lawton established a short position in Myogen's highflying stock "at $39 and change" before the company's disappointing announcement.

...Lawton says. "I've seen stocks with twisted market caps based on their potential and the whims of the marketplace. ... But to me, net-net, this is a $20 stock -- on a very, very good day."

Me think they may have shorted a little before the $39 price. Source Capital... those guys do love their fat lunches.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News